Pharmaceuticals & Biotechnology

Ennature Biopharma Limited

ISIN: INE2WCT01016 · Data as of Sep 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
1
vs Last Month
+1 funds
Total Value
₹3.69 Cr
Avg Weight
0.19%
New Entries
1
Exits
0
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
📋 What Changed This Month Ennature Biopharma Limited is currently held by 1 active mutual funds with total exposure of ₹3.69 Cr. This month 1 fund entered and 0 funds exited. WhiteOak Capital Special Opportunities Fund - Direct Growth has the highest allocation at 0.19%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 1 Months?

Month Funds AUM (Cr) AMCs Status
Sep 2026 REFERENCE 1 ₹4 48 / 49

📌 Portfolio changes below are based on Sep 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Sep 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

▼ Exits (0)
No exits this month
↑ Increased (0)
No increases this month
↓ Decreased (0)
No decreases this month
By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Equity 1 0.19%
All Holdings

Which 1 Active Funds Hold Ennature Biopharma Limited?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
WhiteOak Capital Special Opportunities Fund - Direct Growth
WhiteOak Capital Mutual Fund
Equity 0.19% ₹3.69 Cr NEW
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.